283 phd-rehabilitation-engineering-computer-science positions at University of Manchester
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
well as those in technology and infrastructure. Both will be crucial to the Manchester 2035 strategy. You will manage and deliver all DDAR business-side objectives of the CRM migration project, reporting
-
to study the structure and dynamics of bacterial secretesome. In particular, the project will develop the hydrogen deuterium exchange mass spectrometry (HDX-MS) technology to interrogate the conformational
-
offshore energy infrastructure. The post holder will work closely with European academic and industrial partners, integrating advanced materials science with high-voltage engineering to address one
-
This 3-year research associate position forms part of an EPSRC Prosperity Partnership between The University of Manchester and healthcare provider Bupa. The research programme aims to address
-
on the online programme application and supporting documents. Application form Additional documentation Your full online application must include; A 1,500 word PhD research proposal. Times New Roman, Font
-
such as quantisation and sampling are often ignored during the verification of AI models. Yet, they are pervasive phenomena in any engineering application where digital compute platforms interact with
-
-Robot Interaction researchers as well as professional Engineers from Amentum. The successful candidate will contribute to the wider joint research programme tackling these interrelated challenges and will
-
Background This PDRA position is a key part of the Future Vaccines Manufacturing Research Hub (Vax-Hub Sustainable), led by UCL Biochemical Engineering and the University of Oxford with a number of
-
internal and external stakeholders. For the post of Research Assistant, an MSc (or equivalent) in a relevant discipline is required. For the post of Research Associate, a PhD (or equivalent) in a relevant
-
highlights the urgent need for novel approaches. Antimicrobial peptides (AMPs) are an emergent technology platform which are cost-effective to manufacture and have potential to control wound infection. Despite